ARTICLES ON ISCHEMIC HEART DISEASE
Dubious benefits of dual antiplatelet therapy after coronary surgery: new evidence in 2201 patients
A prospective randomized study including more than 2000 patients compared the outcomes of single antiplatelet therapy with aspirin versus dual antiplatelet therapy with aspirin and ticagrelor during the year following coronary artery bypass grafting (CABG) performed for acute coronary syndrome (ACS).
Results of no-touch versus conventionally harvested saphenous vein use in coronary artery bypass surgery: a meta-analysis of randomized clinical trials
This article presents a meta-analysis of randomized trials comparing the no-touch technique with the conventional harvesting technique, all including imaging-based follow-up over a mean period of 3.7 years, aiming to address the apparent discordance in the current literature.
I, robot, in coronary surgery
Initial experience from a chinese center in minimally invasive multivessel coronary revascularization combining robotic assistance and a minimally invasive surgical approach
Clinical practice guidelines for heroic surgery: consensus on mechanical complications of myocardial infarction
AATS consensus document on the surgical management of mechanical complications following acute myocardial infarction.
Long-term survival in patients with preserved ejection fraction and three-vessel coronary artery disease undergoing surgical revascularization
This multicenter retrospective study analyzes long-term survival benchmarks among patients with preserved left ventricular ejection fraction (LVEF) and three-vessel coronary artery disease (CAD) who underwent isolated surgical revascularization, comparing their survival with an age- and sex-matched cohort from the general U.S. population.
Percutaneous versus surgical revascularization in unprotected left main coronary artery disease: does age matter?
A meta-analysis including 14 studies with a total of 24.767 patients assessed the outcomes of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) according to age in patients with unprotected left main coronary artery (LMCA) disease.
Prophylactic left atrial appendage occlusion during coronary surgery in patients without prior atrial fibrillation: how far should we go?
This historical cohort observational study from the University of Virginia analyzed short-term outcomes in patients without preoperative atrial fibrillation who underwent concomitant prophylactic left atrial appendage closure during coronary artery bypass grafting.
Myocardial viability before revascularization: does it make a difference?
This retrospective single-center study assessed the impact of quantifying myocardial viability, using FDG-PET and cardiac magnetic resonance imaging (CMR), prior to surgical coronary revascularization in patients with left ventricular dysfunction.
Does it make sense to revascularize occluded vessels? Seeking for clarity
Subanalysis of the REGROUP trial assessing 5-year outcomes after surgical revascularization in patients with at least one totally occluded coronary vessel versus those without any occlusions.
Double mammary artery in coronary revascularization: in situ or not in situ—is that the question?
This retrospective study evaluated the relationship between graft configuration in double internal thoracic artery (ITA) coronary artery bypass grafting (CABG) and the incidence of major adverse cardiovascular events (MACEs), as well as graft patency.